GlassScriptPhysician profile
Barbara S Giesser
NPI 1235154055
$4,248.22
in general payments reported to CMS, 2019-2025
17 companies · $385 in 2025
The $385 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,805 · 2021: $148 · 2022: $508 · 2023: $131 · 2024: $271 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435 · Education: $203 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.75 |
| Education | $202.84 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Greenwich Biosciences, INC. | $2,706.00 | 2020 | |
| Genentech USA, INC. | $519.14 | 2020-2025 | Ocrevus, Ocrevus Zunovo |
| Novartis Pharmaceuticals Corporation | $305.24 | 2021-2022 | |
| Amgen INC. | $228.04 | 2024-2025 | Uplizna |
| Biogen, INC. | $181.65 | 2020-2025 | Tysabri |
| Horizon Therapeutics Plc | $68.78 | 2021-2022 | |
| Emd Serono, INC. | $34.42 | 2022 | |
| Ascendis Pharma Endocrinology INC | $25.69 | 2025 | Yorvipath |
| Baxter Healthcare | $23.98 | 2022 | |
| Caris Mpi, INC. | $23.89 | 2025 | Mi Cancer Seek |
| Cycle Pharmaceuticals INC | $22.39 | 2025 | Tascenso Odt |
| Medexus Pharma, INC. | $22.37 | 2022 | |
| Alexion Pharmaceuticals, INC. | $20.74 | 2020 | |
| Lilly USA, LLC | $19.71 | 2025 | Zepbound |
| Genzyme Corporation | $16.19 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Banner Life Sciences, LLC | $15.45 | 2022 | |
| Ge Healthcare | $14.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Giesser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.